Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		67 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (646,109)	$ (1,174,841)	$ (5,538,216)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	24,375	24,374	159,790
Allowance for uncollectible notes receivable		13,867	38,867
Amortization of deferred finance costs	45,127	1,252	78,619
Interest expense on fair value adjustments of convertible notes payable	50,278	(18,279)	298,207
Interest accrued on note receivable			(11,705)
Write-off of uncollectible deposit			20,000
Loss on extinguishment of debt	31,398	277,489	375,314
Loss on impairment		21,000	21,000
Stock issued for services	89,386	317,169	1,797,356
Stock issued to satisfy legal services			40,557
Stock issued for financing fees			3,500
Changes in operating assets and liabilities:
Increase decrease Prepaid expenses			(43,860)
Advance from shareholder	(1,016)		(1,016)
Deposits and other receivables		(48,702)	(23,346)
Increase decrease Accounts payable and accrued liabilities	20,243	184,173	264,909
Net cash used in operating activities	(386,318)	(402,498)	(2,520,024)
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds from notes receivable			(25,000)
Purchase of securities	(12,000)	(21,000)	(34,100)
Acquisition of equipment			(325,000)
Net cash provided by (used in) investing activities	(12,000)	(21,000)	(384,100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of common stock	249,000	272,670	2,038,144
Proceeds from the issuance of convertible notes, related parties	50,000		56,000
Proceeds from the issuance of convertible notes, nonrelated parties	95,480	20,000	608,780
Proceeds from the issuance of notes payable	10,000	155,000	286,500
Proceeds from the issuance of notes payable, related parties		5,000	6,000
Payments on convertible notes payable	(5,000)	(25,000)	(30,000)
Payments on notes payable	(10,000)		(65,000)
Payments on notes payable- related parties			(1,000)
Proceeds from loans from stockholders	5,000		40,925
Payments on stockholder loans	(5,000)	(5,225)	(36,225)
Net cash provided by financing activities	389,480	422,445	2,904,124
CHANGE IN CASH	(8,838)	(1,053)
CASH, BEGINNING OF PERIOD	8,838	3,071
CASH, ENDING OF PERIOD		2,018
NONCASH FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued for investment	9,800		9,800
Common stock issued for loan financing fees	1,500	1,250	7,750
Common stock issued to satisfy minimum value guarantee			87,667
Common stock issued to satisfy legal services			40,559
Convertible debt converted to common stock including accrued interest	208,500	499,910	1,186,762
Common stock issued to satisfy debt	266,690	40,559	266,690
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for Interest			$ 3,660